基于社区慢病防治的消白方治疗慢性肾炎(脾肾阳虚型)的临床研究

Clinical study on treating chronic nephritis of the Pishen Yangxu type with the Xiaobai prescription

目的:更进一步对社区慢病防治的消白方治疗慢性肾炎(脾肾阳虚型)的临床疗效进行探究。方法:择取2016年1月-2017年1月于我社区卫生服务中心接受慢性肾炎(脾肾阳虚型)治疗的80例患者进行回顾分析。依据随机数字表法及对每位慢性肾炎(脾肾阳虚型)所采取治疗方案的不同将其均分至肾炎康复片治疗的对照组与"消白方+社区管理"的观察组,对比两种不同临床治疗方案对慢性肾炎(脾肾阳虚型)患者临床疗效的差异。结果:无论在临床总有效率方面,还是在提高居民知晓率方面,行"消白方+社区管理"治疗的观察组均明显优于常规肾炎康复片治疗的对照组,P<0.05。结论:对于慢性肾炎(脾肾阳虚型)患者实施"消白方+社区管理"治疗方案不仅能够提升临床有效率,而且能够极大提升居民知晓率,进而有效降低慢性肾炎的发病率。

Objective:To explore efficacy of the Xiaobai prescription(消白方)on chronic nephritis of the Pishen Yangxu type(脾肾阳虚型).Methods:80 patients were divided into 2 groups.The control group was given the Shenyan Kangfu tablet(肾炎康复片);and the observation group was given the Xiaobai prescription plus community management.Clinical efficiency in two groups were compared.Results:The total efficiency and the residents awareness rate in the observation group were better,P<0.05.Conclusion:The Xiaobai prescription on chronic nephritis of the Pishen Yangxu type can improve the total efficiency and the residents awareness rate,and effectively reduce the incidence of chronic nephritis.